{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T21:01:19Z","timestamp":1789851679140,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32371273"],"award-info":[{"award-number":["32371273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32571398"],"award-info":[{"award-number":["32571398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2022ZD0205800"],"award-info":[{"award-number":["2022ZD0205800"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Structure"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.str.2026.08.012","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:48:34Z","timestamp":1789742914000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structural basis of QX007N neutralizing interleukin-33 for asthma and COPD treatment"],"prefix":"10.1016","author":[{"given":"Qi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6016-8399","authenticated-orcid":false,"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.str.2026.08.012_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003331","article-title":"The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'?","volume":"3","author":"Moussion","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2026.08.012_bib2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.immuni.2009.05.007","article-title":"Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases","volume":"31","author":"L\u00fcthi","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.str.2026.08.012_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/imr.12619","article-title":"Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family","volume":"281","author":"Cayrol","year":"2018","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.str.2026.08.012_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","article-title":"IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines","volume":"23","author":"Schmitz","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.str.2026.08.012_bib5","doi-asserted-by":"crossref","first-page":"18660","DOI":"10.1073\/pnas.0705939104","article-title":"IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells","volume":"104","author":"Ali","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2026.08.012_bib6","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.179.4.2551","article-title":"IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex","volume":"179","author":"Chackerian","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib7","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/labinvest.3700663","article-title":"IL-33 can promote survival, adhesion and cytokine production in human mast cells","volume":"87","author":"Iikura","year":"2007","journal-title":"Lab. Invest."},{"key":"10.1016\/j.str.2026.08.012_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1182\/blood-2008-05-157818","article-title":"Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33","volume":"113","author":"Pecaric-Petkovic","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.str.2026.08.012_bib9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.02.026","article-title":"IL-33-activated dendritic cells induce an atypical TH2-type response","volume":"123","author":"Rank","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4168\/aair.2011.3.2.81","article-title":"IL-33 and Airway Inflammation","volume":"3","author":"Oboki","year":"2011","journal-title":"Allergy Asthma Immunol. Res."},{"key":"10.1016\/j.str.2026.08.012_bib11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2014.01.011","article-title":"Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation","volume":"40","author":"Halim","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.str.2026.08.012_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.immuni.2017.08.004","article-title":"IL-1 Family Cytokines Use Distinct Molecular Mechanisms to Signal through Their Shared Co-receptor","volume":"47","author":"G\u00fcnther","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.str.2026.08.012_bib13","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/cells11010107","article-title":"IL-33, an Alarmin of the IL-1 Family Involved in Allergic and Non Allergic Inflammation: Focus on the Mechanisms of Regulation of Its Activity","volume":"11","author":"Cayrol","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.str.2026.08.012_bib16","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in Tissue Homeostasis, Injury, and Inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.str.2026.08.012_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1146","article-title":"Interleukin (IL)-33: an orchestrator of immunity from host defence to tissue homeostasis","volume":"9","author":"Zhou","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/imr.12552","article-title":"IL-33: biological properties, functions, and roles in airway disease","volume":"278","author":"Drake","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.str.2026.08.012_bib19","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","article-title":"Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells","volume":"183","author":"Pr\u00e9fontaine","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib20","doi-asserted-by":"crossref","first-page":"631-7.e78","DOI":"10.1016\/j.jaci.2010.06.030","article-title":"Analyses of shared genetic factors between asthma and obesity in children","volume":"126","author":"Mel\u00e9n","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1056\/NEJMoa0906312","article-title":"A large-scale, consortium-based genomewide association study of asthma","volume":"363","author":"Moffatt","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.str.2026.08.012_bib22","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jaci.2020.04.051","article-title":"Phenotypic and functional translation of IL33 genetics in asthma","volume":"147","author":"Ketelaar","year":"2021","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib23","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1172\/JCI65570","article-title":"Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease","volume":"123","author":"Byers","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.str.2026.08.012_bib24","doi-asserted-by":"crossref","first-page":"L619","DOI":"10.1152\/ajplung.00305.2014","article-title":"Increased IL-33 expression in chronic obstructive pulmonary disease","volume":"308","author":"Xia","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.str.2026.08.012_bib25","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.3390\/ijms24108702","article-title":"The Role of IL-33\/ST2 in COPD and Its Future as an Antibody Therapy","volume":"24","author":"Riera-Mart\u00ednez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.str.2026.08.012_bib26","doi-asserted-by":"crossref","first-page":"14918","DOI":"10.1073\/pnas.1308651110","article-title":"Structural insights into the interaction of IL-33 with its receptors","volume":"110","author":"Liu","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.str.2026.08.012_bib27","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1056\/NEJMoa1607751","article-title":"Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma","volume":"375","author":"Dimopoulos","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.str.2026.08.012_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.coph.2018.05.010","article-title":"Monoclonal antibodies as immunomodulatory therapy against cancer and autoimmune diseases","volume":"41","author":"Hafeez","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.str.2026.08.012_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2026.2639673","article-title":"Structures of clinical antibodies bound to IL-33 uncover two distinct epitopes underlying differential efficacy","volume":"18","author":"Chen","year":"2026","journal-title":"mAbs"},{"key":"10.1016\/j.str.2026.08.012_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155773","article-title":"IL-1 family cytokines as drivers and inhibitors of trained immunity","volume":"150","author":"Teufel","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.str.2026.08.012_bib31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.str.2026.08.012_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.str.2026.08.012_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232311","article-title":"Rapid and robust antibody Fab fragment crystallization utilizing edge-to-edge beta-sheet packing","volume":"15","author":"Lieu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.str.2026.08.012_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00831-2025","article-title":"IL-33, inflammation and mucus in COPD: the final FRONTIER?","volume":"66","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.str.2026.08.012_bib35","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1164\/rccm.201406-1039OC","article-title":"IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo","volume":"190","author":"Jackson","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.str.2026.08.012_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.131721","article-title":"Structural basis for the recognition of IFNAR1 by the humanized therapeutic monoclonal antibody QX006N for the treatment of systemic lupus erythematosus","volume":"268","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.str.2026.08.012_bib42","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.str.2009.08.009","article-title":"Structure of IL-33 and Its Interaction with the ST2 and IL-1RAcP Receptors\u2014Insight into Heterotrimeric IL-1 Signaling Complexes","volume":"17","author":"Lingel","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.str.2026.08.012_bib36","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.str.2026.08.012_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1107\/S0907444906045975","article-title":"Solving structures of protein complexes by molecular replacement with Phaser","volume":"63","author":"McCoy","year":"2007","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2026.08.012_bib38","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2026.08.012_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","article-title":"PHENIX: a comprehensive Python-based system for macromolecular structure solution","volume":"66","author":"Adams","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.str.2026.08.012_bib40","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1107\/S1600577524011597","article-title":"Status of macromolecular crystallography beamlines at SSRF","volume":"32","author":"Kong","year":"2025","journal-title":"J. Synchrotron Radiat."},{"key":"10.1016\/j.str.2026.08.012_bib43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."}],"container-title":["Structure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212626002595?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969212626002595?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:01:44Z","timestamp":1789848104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969212626002595"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":43,"alternative-id":["S0969212626002595"],"URL":"https:\/\/doi.org\/10.1016\/j.str.2026.08.012","relation":{},"ISSN":["0969-2126"],"issn-type":[{"value":"0969-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis of QX007N neutralizing interleukin-33 for asthma and COPD treatment","name":"articletitle","label":"Article Title"},{"value":"Structure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.str.2026.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}